Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR)
CUSIP: 17322U306
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 24,189,141
- Total 13F shares
- 1,720,560
- Share change
- +1,037,141
- Total reported value
- $1,336,933
- Put/Call ratio
- 0%
- Price per share
- $0.78
- Number of holders
- 39
- Value change
- +$797,534
- Number of buys
- 16
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 17322U306?
CUSIP 17322U306 identifies CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 17322U306:
Top shareholders of CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
— |
9.9%
|
2,394,725
|
$2,059,464 | +$635,578 | 31 Dec 2025 | |
| Leonard L. Mazur |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
501,202
mixed-class rows
|
$574,299 | — | 08 Aug 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.69%
|
166,390
|
$206,323 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
119,771
|
$148,536 | — | 30 Sep 2025 | |
| Myron Z. Holubiak |
3/4/5
|
Vice Chairman, Director |
—
mixed-class rows
|
106,501
mixed-class rows
|
$124,316 | — | 08 Aug 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.29%
|
69,851
|
$86,615 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
48,186
|
$59,751 | — | 30 Sep 2025 | |
| Jaime Bartushak |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
410,353
mixed-class rows
|
$45,265 | — | 07 Nov 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
27,025
|
$33,511 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
25,913
|
$32,132 | — | 30 Sep 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.11%
|
25,400
|
$31,496 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
23,271
|
$28,856 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
21,803
|
$27,036 | — | 30 Sep 2025 | |
| Arkadios Wealth Advisors |
13F
|
Company |
0.08%
|
20,000
|
$24,800 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
18,885
|
$23,417 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
15,922
|
$19,743 | — | 30 Sep 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.04%
|
10,044
|
$12,000 | — | 30 Sep 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.04%
|
9,556
|
$11,000 | — | 30 Sep 2025 | |
| Carol Webb |
3/4/5
|
Director |
—
mixed-class rows
|
136,835
mixed-class rows
|
$8,876 | — | 07 Nov 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0.03%
|
7,083
|
$8,783 | — | 30 Sep 2025 | |
| CHELSEA COUNSEL CO |
13F
|
Company |
0.02%
|
4,626
|
$5,737 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.02%
|
4,020
|
$4,985 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
1,617
|
$2,005 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,487
|
$1,975 | — | 30 Sep 2025 | |
| Eugene Myron Holuka |
3/4/5
|
Director |
—
mixed-class rows
|
127,367
mixed-class rows
|
$1,775 | — | 07 Nov 2024 | |
| Legacy Wealth Managment, LLC/ID |
13F
|
Company |
0%
|
930
|
$1,154 | — | 30 Sep 2025 | |
| Luminist Capital LLC |
13F
|
Company |
0%
|
435
|
$596 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
422
|
$523 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
407
|
$504 | — | 30 Sep 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
343
|
$425 | — | 30 Sep 2025 | |
| Murphy & Mullick Capital Management Corp |
13F
|
Company |
0%
|
160
|
$251 | — | 30 Sep 2025 | |
| Princeton Global Asset Management LLC |
13F
|
Company |
0%
|
160
|
$198 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
120
|
$149 | — | 30 Sep 2025 | |
| Smallwood Wealth Investment Management, LLC |
13F
|
Company |
0%
|
120
|
$148 | — | 30 Sep 2025 | |
| Quent Capital, LLC |
13F
|
Company |
0%
|
108
|
$134 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
107
|
$133 | — | 30 Sep 2025 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
84
|
$104 | — | 30 Sep 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
80
|
$99 | — | 30 Sep 2025 | |
| Fairscale Capital, LLC |
13F
|
Company |
0%
|
42
|
$52 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
40
|
$50 | — | 30 Sep 2025 | |
| Myron Czuczman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
300,000
|
— | — | 07 Nov 2024 | |
| Dennis M. Mcgrath |
3/4/5
|
Director |
—
class O/S missing
|
125,000
|
— | — | 07 Nov 2024 | |
| Robert Joseph Smith |
3/4/5
|
Director |
—
class O/S missing
|
125,000
|
— | — | 07 Nov 2024 | |
| Suren G. Dutia |
3/4/5
|
Director |
—
class O/S missing
|
125,000
|
— | — | 07 Nov 2024 | |
| Howard Safir |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
— | — | 04 Oct 2022 | |
| William Kane |
3/4/5
|
Director |
—
class O/S missing
|
75,000
|
— | — | 04 Oct 2022 |
Institutional Holders of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) as of Q4 2025
As of 31 Dec 2025,
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,720,560 shares.
The largest 10 holders included
HEIGHTS CAPITAL MANAGEMENT, INC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, UBS Group AG, BlackRock, Inc., TWO SIGMA INVESTMENTS, LP, Asset Advisory Group, Inc., NORTHERN TRUST CORP, and TWO SIGMA SECURITIES, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
34
Q4 2025 holders
39
Holder diff
5
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.